Many research groups worldwide are investing significant time and resources in studying drug mechanism of action (MOA) and its impact on disease pathology. One critical challenge they encounter is access to a centralized source that contains high-quality, manually curated literature knowledge. To meet this need, we launched QIAGEN Biomedical KB-HD, the expert-curated database backing QIAGEN Ingenuity Pathway Analysis (IPA), to enable the scientific community and help accelerate drug discovery.

You will learn to use Biomedical KB-HD to:

• Easily pull up relevant literature findings for a drug of interest
• Generate a novel mechanism of action (MOA) for this drug and its effect on the disease indication of interest
• Identify new applications for this drug (drug repurposing)
• Investigate mutational impact on drug MOA